Keyphrases
Alzheimer's Disease
100%
Cerebrospinal Fluid
52%
Memory Clinic
29%
Dementia with Lewy Bodies
25%
Mild Cognitive Impairment
25%
Dementia
20%
Idiopathic Normal Pressure Hydrocephalus (iNPH)
20%
Cerebral Blood Flow
18%
Healthy Controls
18%
Positron Emission Tomography
17%
Neurodegenerative Diseases
16%
Physical Exercise
16%
Single-photon Emission Computed Tomography (SPECT)
13%
Neurofilament Light (NF-L)
12%
Dementia Diagnosis
11%
Cerebrospinal Fluid Biomarkers
11%
Cognitive Function
11%
Bipolar Disorder
11%
5-HT2A Receptor
11%
Aerobic Exercise
11%
Mild Alzheimer's Disease
11%
Receptor Binding
10%
High-intensity Exercise
10%
Frontotemporal Dementia
10%
Moderate to Severe
10%
Regional Cerebral Blood Flow (rCBF)
9%
Dementia Diseases
9%
Human Brain
9%
Altanserin
9%
Cerebral Glucose Metabolism
9%
Magnetic Resonance Imaging
9%
Cognitive Impairment
8%
Glucose Metabolism
8%
5-HT4 Receptor
8%
Cognitive Decline
8%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
8%
Blood-brain Barrier
7%
Phosphorylated tau
7%
Quality of Life
7%
Disorder Control
7%
Technetium-99m
7%
Brain Imaging
6%
Visual Rating
6%
Differential Diagnosis
6%
Diagnostic Accuracy
6%
Neurodegeneration
6%
PET Study
6%
Vascular Dementia
6%
Randomized Controlled Trial
6%
PiB-PET
6%
Neuroscience
Alzheimer's Disease
95%
Dementia with Lewy Bodies
29%
Positron Emission Tomography
28%
Positron Emission Tomography
28%
Metabolic Pathway
26%
Fluorine-18
24%
Mild Cognitive Impairment
24%
Normal Pressure Hydrocephalus
19%
Amyloid
18%
Neurodegenerative Disorder
17%
Magnetic Resonance Imaging
17%
Cognitive Disorders
15%
5-HT2A Receptor
13%
Single-Photon Emission Computed Tomography
13%
Blood Brain Barrier
13%
Cognitive Function
12%
Receptor Binding
11%
Magnetic Resonance Imaging
11%
Bipolar Disorder
11%
Neurodegeneration
10%
Frontotemporal Dementia
10%
Altanserin
9%
Depression
8%
Beta Amyloid
8%
Brain Imaging
8%
Serotonin
7%
2-Deoxy-D-Glucose
7%
Technetium-99m
7%
Eicosanoid Receptor
7%
Vascular Dementia
7%
Neurofilament Light Chain
7%
Brain Metabolism
7%
Glucose Transport
6%
5-HT4 Receptor
6%
Differential Diagnosis
6%
Serotonergic
5%
Ketone Bodies
5%
Neurofilament
5%
Oxidative Stress
5%
In Vivo
5%
Medicine and Dentistry
Alzheimer's Disease
38%
Biological Marker
31%
Cerebrospinal Fluid
23%
Diagnosis
19%
Magnetic Resonance Imaging
13%
Systematic Review
13%
Tau
11%
Positron Emission Tomography
11%
Amyloid
11%
Mild Cognitive Impairment
10%
Positron Emission Tomography
10%
Brain Blood Flow
10%
Disease
9%
Diffuse Lewy Body Disease
9%
Exercise
9%
Patient with Alzheimer's Disease
8%
Aerobic Exercise
7%
Fluorodeoxyglucose F 18
6%
Normal Pressure Hydrocephalus
6%
Neurofilament
6%
Frontotemporal Lobar Degeneration
6%
Cognitive Defect
6%
Amyloid Beta
6%
Clinician
6%
Symptom
5%
Glucose Uptake
5%